| Date Filed | Type | Description |
| 03/25/2021 |
GN
| Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results |
| 02/17/2021 |
GN
| Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month |
| 02/12/2021 |
GN
| Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference |
| 02/10/2021 |
GN
| Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report |
| 02/04/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
GN
| Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock |
| 01/04/2021 |
GN
| Aspira Women's Health, Inc. to Participate in Virtual Investor Events |
| 11/19/2020 |
GN
| Aspira Women's Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection Test |
| 11/10/2020 |
GN
| Aspira Women's Health, Inc. Strengthens Executive Leadership with New Appointments |
| 11/09/2020 |
GN
| Aspira Women's Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks |
| 11/05/2020 |
GN
| Aspira Women's Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum |
| 11/04/2020 |
GN
| Aspira Women's Health, Inc. to Report Third Quarter 2020 Financial Results on November 12th |
| 10/09/2020 |
GN
| Aspira Women's Health, Inc. to Present at MicroCap Rodeo Best Ideas Bowl October 13-16 |
| 09/15/2020 |
GN
| Aspira Women's Health, Inc. to Host Key Opinion Leader Call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives |
| 09/08/2020 |
GN
| Aspira Women's Health, Inc. to Present at Cantor Virtual Healthcare Conference |
| 08/14/2020 |
GN
| UPDATE – Aspira Women's Health Reports Second Quarter 2020 Financial Results |
| 07/31/2020 |
GN
| Aspira Women's Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th |
| 07/01/2020 |
GN
| Aspira Women's Health Inc. Announces Equity Financing of Approximately $11 Million |
| 11/27/2019 |
SC 13G/A
| Allied World Assurance Co Holdings, AG reports a 16.7% stake in Crescent Capital BDC, Inc. |
| 02/02/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/08/2017 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/07/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/04/2017 |
8-K
| Quarterly results |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/03/2017 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 08/03/2017 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 07/31/2017 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 07/18/2017 |
8-K
| Form 8-K - Current report: |
| 07/17/2017 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
| 07/14/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/12/2017 |
8-K
| Form 8-K - Current report: |
| 07/07/2017 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
|